A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission by Martin JN, Mzolo S, Mosam A, Butler LM

Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by HSP90 inhibition by Nassar, ZD, Mah, CY, Centenera, MM, Irani, S, Sadowski, MC, Scott, JS, Nguyen, EV, Nagarajan, SR, Moldovan M, Lynn, DJ, Daly, RJ, Hoy, AJ, Butler, LM

Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer by Mah, CY, Nguyen, ADT, Niijima, T, Helm, M, Dehairs, J, Ryan, FJ, Ryan, N, Quek, L, Hoy, AJ, Don, AS, Mills, IG, Swinnen, JV, Lynn, DJ, Nassar, ZD, Butler, LM

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth by Gillis, JL, Hinneh, JA, Ryan, NK, Irani, S, Moldovan, M, Quek, L-E, Shrestha, RK, Hanson, AR, Xie, J, Hoy, AJ, Holst, J, Centenera, MM, Mills, IG, Lynn, DJ, Selth, LA, Butler, LM

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research by Brennen, WN, Le Magnen, C, Karkampouna, S, Anselmino, N, Bock, N, Choo, N, Clark, AK, Coleman, IM, Dolgos, R, Ferguson, AM, Goode, DL, Krutihof‐de Julio, M, Navone, NM, Nelson, PS, O'Neill, E, Porter, LH, Ranasinghe, W, Sunada, T, Williams, ED, Butler, LM, Corey, E, van Weerden, WM, Taylor, RA, Risbridger, GP

ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer by Centenera, MM, Scott, JS, Machiels, J, Nassar, ZD, Miller, DC, Zininos, I, Dehairs, J, Burvenich, IJG, Zadra, G, Chetta, P, Bango, C, Evergren, E, Ryan, NK, Gillis, JL, Mah, CY, Tieu, T, Hanson, AR, Carelli, R, Bloch, K, Panagopoulos, V, Waelkens, E, Derua, R, Williams, ED, Evdokioou, A, Cifuentes-Rius, A, Voelcker, NH, Mills, IG, Tilley, WD, Scott, AM, Loda, M, Selth, LA, Swinnen, JV, Butler, LM